Goldman Sachs Group Inc Neuronetics, Inc. Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 442,918 shares of STIM stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
442,918
Previous 630,393 29.74%
Holding current value
$1.4 Million
Previous $2.32 Million 33.38%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$3.32 - $4.65 $622,417 - $871,758
-187,475 Reduced 29.74%
442,918 $1.55 Million
Q1 2025

May 09, 2025
BUY
$1.49 - $5.54 $908,920 - $3.38 Million
610,014 Added 2993.35%
630,393 $2.32 Million
Q4 2024

Feb 11, 2025
BUY
$0.59 - $1.49 $12,023 - $30,364
20,379 New
20,379 $30,000
Q1 2024

May 15, 2024
SELL
$2.68 - $4.8 $10,768 - $19,286
-4,018 Reduced 25.33%
11,846 $56,000
Q4 2023

Feb 13, 2024
SELL
$1.05 - $2.9 $349 - $965
-333 Reduced 2.06%
15,864 $46,000
Q3 2023

May 14, 2024
BUY
$1.29 - $2.22 $429 - $739
333 Added 2.1%
16,197 $21,000
Q3 2023

Nov 14, 2023
SELL
$1.29 - $2.22 $17,998 - $30,973
-13,952 Reduced 46.28%
16,197 $21,000
Q2 2023

May 14, 2024
SELL
$2.07 - $2.92 $22,244 - $31,378
-10,746 Reduced 26.28%
30,149 $64,000
Q2 2023

Aug 14, 2023
SELL
$2.07 - $2.92 $22,244 - $31,378
-10,746 Reduced 26.28%
30,149 $64,000
Q1 2023

May 14, 2024
SELL
$2.81 - $6.71 $14,156 - $33,804
-5,038 Reduced 10.97%
40,895 $119,000
Q1 2023

May 11, 2023
SELL
$2.81 - $6.71 $14,156 - $33,804
-5,038 Reduced 10.97%
40,895 $119,000
Q4 2022

May 14, 2024
SELL
$2.74 - $6.87 $385,383 - $966,272
-140,651 Reduced 75.38%
45,933 $315,000
Q4 2022

Feb 13, 2023
SELL
$2.74 - $6.87 $385,383 - $966,272
-140,651 Reduced 75.38%
45,933 $315,000
Q3 2022

May 14, 2024
SELL
$2.35 - $4.66 $38,822 - $76,983
-16,520 Reduced 8.13%
186,584 $593,000
Q3 2022

Nov 10, 2022
SELL
$2.35 - $4.66 $38,822 - $76,983
-16,520 Reduced 8.13%
186,584 $0
Q2 2022

May 14, 2024
BUY
$2.09 - $3.71 $391,331 - $694,660
187,240 Added 1180.28%
203,104 $652,000
Q2 2022

Aug 15, 2022
BUY
$2.09 - $3.71 $29,239 - $51,902
13,990 Added 7.4%
203,104 $652,000
Q1 2022

May 16, 2022
SELL
$2.84 - $4.52 $80,886 - $128,734
-28,481 Reduced 13.09%
189,114 $573,000
Q4 2021

Feb 14, 2022
BUY
$3.87 - $6.59 $157,714 - $268,562
40,753 Added 23.04%
217,595 $971,000
Q3 2021

Nov 10, 2021
BUY
$6.22 - $15.54 $1.1 Million - $2.75 Million
176,842 New
176,842 $1.16 Million

Others Institutions Holding STIM

# of Institutions
97
Shares Held
18.6M
Call Options Held
49.6K
Put Options Held
78.8K
View Full List

About Neuronetics, Inc.

STIM Quotes by TradingView
  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $85.1M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email